TrialBritish journal of cancer2023

A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations.

Subotheni Thavaneswaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.